Association between polychlorinated biphenyls and Parkinson's disease neuropathology

NeuroToxicology

Volumn 33, Issue 5, 2012, Pages 1298-1304

  Hatcher Martin, Jaime M ^a   Gearing, Marla ^a   Steenland, Kyle ^b   Levey, Allan I ^a   Miller, Gary W ^a,b   Pennell, Kurt D ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Tufts University   (United States)

Author keywords

Exposure; Mass spectrometry; Neurodegenerative disease; Parkinson's disease; PCB; Polychlorinated biphenyl; Sex

Indexed keywords

POLYCHLORINATED BIPHENYL;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS FRAGMENTOGRAPHY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; STRIATAL DEPIGMENTATION; STRIATONIGRAL DEGENERATION;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; ENVIRONMENTAL POLLUTANTS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; PARKINSON DISEASE; POLYCHLORINATED BIPHENYLS; POSTMORTEM CHANGES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84867232219     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.08.002     Document Type: Article

References (36)

1. ATSDR (Agency for Toxic Substances and Disease Registry), 2000. Toxicological Profile for Polychlorinated Biphenyls (PCBs). US Dept of Health and Human Services - Public Health Service. (last accessed 08.09.07). http://www.atsdr.cdc.gov/toxprofiles/tp17.html.
2. Bachour G., Failing K., Georgii S., Elmadfa I., Brunn H. Species and organ dependence of PCB contamination in fish, foxes, roe deer, and humans. Arch Environ Contam Toxicol 1998, 35:666-673.
3. Bemis J.C., Seegal R.F. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content. Toxicol Sci 2004, 80:288-295.
4. Bletchly J.D. Production, current use and possible rates of future disposal in OECD member countries. Proceedings of the PCB-seminar 1983, 343-365. Ministry of Housing, Physical Planning and Environment, The Hague, Netherlands. M.C. Barros, H. Könemann, R. Visser (Eds.).
5. Branchi I., Capone F., Vitalone A., Madia F., Santucci D., Alleva E., et al. Early developmental exposure to BDE 99 or Aroclor 1254 affects neurobehavioural profile: interference from the administration route. NeuroToxicol 2005, 26:183-192.
6. Caudle W.M., Richardson J.R., Delea K.C., Guillot T.S., Wang M., Pennell K.D., et al. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicol Sci 2006, 92:490-499.
7. CFR CoFR, 2011. Electronic Code of Federal Regulations (08.09.11).
8. Chishti M.A., Fisher J.P., Seegal R.F. Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices. Neurotoxicology 1996, 17:653-660.
9. Corrigan F.M., Murray L., Wyatt C.L., Shore R.F. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 1998, 150:339-342.
10. Corrigan F.M., Wienburg C.L., Shore R.F., Daniel S.E., Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 2000, 59:229-234.
11. Dewailly E., Mulvad G., Pedersen H.S., Ayotte P., Demers A., Weber J.P., et al. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 1999, 107:823-828.
12. EPA, 2000. EPA Method 8082A. (last accessed 14.04.11). http://www.caslab.com/EPA-Methods/PDF/EPA-Method-8082A.pdf.
13. Erickson M.D. Analytical chemistry of PCBs 1997, CRC Press LLC, Boca Raton. 2nd ed.
14. Fon E.A., Pothos E.N., Sun B.C., Killeen N., Sulzer D., Edwards R.H. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997, 19:1271-1283.
15. Frame G.M., Cochran J.W., Boewadt S.S. Complete PCB congener distributions for 17 Aroclor mixtures determined by 3 HRGC systems optimized for comprehensive, quantitative, congener-specific analysis. J High Res Chromatogr 1996, 19:657-668.
16. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res 1998, 26:148-153.
17. Grandjean P., White R.F., Sullivan K., Debes F., Murata K., Otto D.A., et al. Impact of contrast sensitivity performance on visually presented neurobehavioral tests in mercury-exposed children. Neurotoxicol Teratol 2001, 23:141-146.
18. Hardin ED, Meehan PW, Melton MA, Shore FL. A critical evaluation of EPA methods 680 and 8080 for PCB analysis. In: Addis G, editor, Proceedings of the 1989 PCB Seminar, vol. 7, Report No. EL/GS/EN-6792; 1990. p. 441-4.
19. Hatcher J.M., Pennell K.D., Miller G.W. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 2008, 29:322-329.
20. Hatcher J.M., Richardson J.R., Guillot T.S., McCormack A.I., Di Monte D.A., Jones D.P., et al. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol 2007, 204:619-630.
21. Jacobson J.L., Jacobson S.W., Humphrey H.E.B. Effects of exposure to PCBs and related compounds on growth and activity in children. Neurotoxicol Teratol 1990, 12:319-326.
22. Lee D.W., Gelein R.M., Opanashuk L.A. Heme-oxygenase-1 promotes polychlorinated biphenyl mixture Aroclor 1254-induced oxidative stress and dopaminergic cell injury. Toxicol Sci 2006, 90:159-167.
23. Malkiewicz K., Mohammed R., Folkesson R., Winblad B., Szutowski M., Benedikz E. Polychlorinated biphenyls alter expression of alpha-synuclein, synaptophysin and parkin in the rat brain. Toxicol Lett 2006, 161:152-158.
24. Mariussen E., Fonnum F. The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters, dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes. Toxicology 2001, 159:11-21.
25. Miller G.W., Erickson J.D., Perez J.T., Penland S.N., Mash D.C., Rye D.B., et al. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp Neurol 1999, 156:138-148.
26. Miller G.W., Gainetdinov R.R., Levey A.I., Caron M.G. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 1999, 20:424-429.
27. Miller G.W., Staley J.K., Heilman C.J., Perez J.T., Mash D.C., Rye D.B., et al. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 1997, 41:530-539.
28. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
29. Mortimer J.A., Goshe K.M., Riley K.P., Markesberry W.R., Snowdon D.A. Delayed recall, hippocampal volume and Alzheimer neuropathology: Findings from the Nun Study. Neurology 2004, 62:428-432.
30. Richardson J.R., Miller G.W. Acute exposure to Aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicol Lett 2004, 148:29-40.
31. Schantz S.L., Widholm J.J., Rice D.C. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 2003, 111:357-576.
32. Seegal R.F., Bush B., Brosch K.O. Sub-chronic exposure of the adult rat to Aroclor 1254 yields regionally-specific changes in central dopaminergic function. Neurotoxicology 1991, 12:55-65.
33. Seegal R.F., Okoniewski R.J., Brosch K.O., Bemis J.C. Polychlorinated biphenyls alter extraneuronal but not tissue dopamine concentrations in adult rat striatum: an in vivo microdialysis study. Environ Health Perspect 2002, 110:1113-1117.
34. Snowdon D.A., Kemper S.J., Mortimer J.A., Greiner L.H., Wekstein D.R., Markesbery W.R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life Findings from the Nun Study. JAMA 1996, 275:528-532.
35. Snowdon D.A., Tully C.L., Smith C.D., Riley K.P., Markesbery W.R. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am J Clin Nutr 2000, 71:993-998.
36. Steenland K., Hein M.J., Cassinelli R.T., Prince M.M., Nilsen N.B., Whelan E.A., et al. Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology 2006, 17:8-13.